Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 900.74M | 902.82M | 841.49M | 881.72M | 974.67M | 603.23M |
Gross Profit | 472.08M | 470.23M | 436.74M | 510.46M | 616.44M | 335.93M |
EBITDA | 386.24M | 182.49M | 433.77M | 321.51M | 388.66M | 300.08M |
Net Income | 120.53M | 121.75M | 130.62M | 117.54M | 208.13M | 79.96M |
Balance Sheet | ||||||
Total Assets | 3.69B | 3.99B | 3.68B | 3.95B | 3.93B | 3.47B |
Cash, Cash Equivalents and Short-Term Investments | 218.85M | 399.58M | 340.33M | 338.20M | 585.54M | 333.49M |
Total Debt | 2.34B | 2.47B | 2.18B | 2.34B | 2.30B | 2.39B |
Total Liabilities | 2.67B | 2.99B | 2.71B | 3.02B | 2.96B | 2.63B |
Stockholders Equity | 893.72M | 897.49M | 863.93M | 817.02M | 828.30M | 711.14M |
Cash Flow | ||||||
Free Cash Flow | 25.86M | -3.82M | 228.34M | 126.09M | 659.89M | -227.15M |
Operating Cash Flow | 32.50M | 1.75M | 237.16M | 132.67M | 665.73M | -226.10M |
Investing Cash Flow | -17.48M | -16.95M | -129.73M | -27.47M | -175.03M | 8.68M |
Financing Cash Flow | -43.37M | 74.95M | -356.11M | -102.06M | -244.40M | 235.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $1.39B | 11.91 | 13.66% | 4.48% | 0.63% | 1.46% | |
71 Outperform | $1.69B | 34.12 | 10.77% | 0.98% | 20.66% | -47.25% | |
71 Outperform | $1.35B | 26.61 | 3.27% | 16.70% | -28.04% | -69.52% | |
68 Neutral | $1.13B | 1.41 | 11.11% | ― | ― | ― | |
67 Neutral | $16.84B | 11.72 | 9.71% | 3.76% | 11.61% | -9.60% | |
65 Neutral | $1.15B | 10.73 | 8.11% | 12.05% | -3.55% | -20.43% | |
61 Neutral | $1.18B | 68.29 | 5.24% | 1.43% | 18.92% | ― |
On June 27, 2025, Susan S. Fleming announced her decision to retire from her role as a director at Virtus Investment Partners, effective at the end of her term in May 2026. Dr. Fleming has served as a director since the company’s inception as an independent public entity in 2009, and her departure marks the end of a significant tenure, during which she held key positions such as Chairperson of the Governance Committee and member of the Audit Committee.
The most recent analyst rating on (VRTS) stock is a Buy with a $264.00 price target. To see the full list of analyst forecasts on Virtus Investment Partners stock, see the VRTS Stock Forecast page.
On May 14, 2025, Virtus Investment Partners held its annual meeting of shareholders where several key proposals were voted on. Shareholders elected directors to serve until the 2026 Annual Meeting, ratified Deloitte & Touche LLP as the independent accounting firm for the fiscal year ending December 31, 2025, and approved executive compensation on an advisory basis. These decisions reflect the company’s ongoing governance practices and commitment to maintaining its operational and financial integrity.
The most recent analyst rating on (VRTS) stock is a Buy with a $264.00 price target. To see the full list of analyst forecasts on Virtus Investment Partners stock, see the VRTS Stock Forecast page.